SEC Form 4 · accession 0001225208-15-011283
Merck & Co., Inc. · MRK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert M Davis
Officer — Exec V-P & Chief Fince Officer
Period of report
May 1, 2015
Accepted (ET)
May 5, 2015 · 4:46 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000310158
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $59.86 | May 1, 2015 | A | 216,718 | A | May 1, 2016 | Apr 30, 2025 | Common Stock | 216,718 | 216,718 | D |
Explanation of responses
- F1The option vests and becomes exercisable in three equal installments on 5/1/2016, 5/1/2017 and 5/1/2018.